Microbiota–mitochondria inter-talk: Consequence for microbiota–host interaction

Pathogens and Disease

Volumn 74, Issue 1, 2018, Pages

  Saint Georges Chaumet, Yann ^a   Edeas, Marvin ^a,b  

^a Microbiota Mitochondria task force   (France)

^b UNIVERSITÉ PARIS 13   (France)

Author keywords

Host bacteria interaction; Inflammation; Microbiota; Mitochondria; Oxidative stress

Indexed keywords

REACTIVE OXYGEN METABOLITE;

ANIMAL; ECOSYSTEM; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; INTESTINE FLORA; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; MITOCHONDRION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ECOSYSTEM; GASTROINTESTINAL MICROBIOME; HOST-PATHOGEN INTERACTIONS; HUMANS; INTESTINAL MUCOSA; MITOCHONDRIA; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84989171980     PISSN: None     EISSN: 2049632X     Source Type: Journal    
DOI: 10.1093/femspd/ftv096     Document Type: Review

References (41)

1. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 2012;13:701–12.
2. Degli Esposti M, Chouaia B, Comandatore F, et al. Evolution of mitochondria reconstructed from the energy metabolism of living bacteria. PLoS One 2014;9:e96566.
3. Donohoe DR, Garge N, Zhang X, et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab 2011;13:517–26.
4. Edeas M, Weissig V. Targeting mitochondria: strategies, innovations and challenges: The future of medicine will come through mitochondria. Mitochondrion 2013;13:389–90.
5. Emre Y, Nübel T. Uncoupling protein UCP2: when mitochondrial activity meets immunity. FEBS Lett 2010;584:1437–42.
6. Foster JA, McVey Neufeld K-A. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 2013;36:305–12.
7. Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013;504:446–50.
8. Garone C, Tadesse S, Hirano M. Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy. Brain 2011;134:3326–32.
9. Gelvin SB. Agrobacterium-mediated plant transformation: the biology behind the “gene-jockeying” tool. Microbiol Mol Biol Rev 2003;67:16–37.
10. Gessner BD, Gillingham MB, Wood T, et al. Association of a genetic variant of carnitine palmitoyltransferase 1A with infections in Alaska Native children. J Pediatr 2013;163:1716–21.
11. Goubern M, Andriamihaja M, Nübel T, et al. Sulfide, the first inorganic substrate for human cells. FASEB J 2007;21:1699–706.
12. Kalghatgi S, Spina CS, Costello JC, et al. Bactericidal antibiotics induce mitochondrial dysfunction and oxidative damage in mammalian cells. Sci Transl Med 2013;5:192ra85.
13. Kamada N, Núñez G. Regulation of the immune system by the resident intestinal bacteria. Gastroenterology 2014;146:1477–88.
14. Kumar A, Wu H, Collier-Hyams LS, et al. The bacterial fermentation product butyrate influences epithelial signaling via reactive oxygen species-mediated changes in cullin-1 neddy-lation. J Immunol 2009;182:538–46.
15. Lebreton A, Stavru F, Cossart P. Organelle targeting during bacterial infection: insights from Listeria. Trends Cell Biol 2015;25:330–8.
16. Leschelle X, Goubern M, Andriamihaja M, et al. Adaptative metabolic response of human colonic epithelial cells to the adverse effects of the luminal compound sulfide. Biochim Bio-phys Acta 2005;1725:201–12.
17. Lin HV, Frassetto A, Kowalik EJ, et al. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS One 2012;7:e35240.
18. Liu H, Bao W, Lin M, et al. Ehrlichia type IV secretion effector ECH0825 is translocated to mitochondria and curbs ROS and apoptosis by upregulating host MnSOD. Cell Microbiol 2012;14:1037–50.
19. Lobet E, Letesson J-J, Arnould T. Mitochondria: a target for bacteria. Biochem Pharmacol 2015;94:173–85.
20. Lucattini R, Likic VA, Lithgow T. Bacterial proteins predisposed for targeting to mitochondria. Mol Biol Evol 2004;21:652–8.
21. Ma J, Coarfa C, Qin X, et al. mtDNA haplogroup and single nucleotide polymorphisms structure human microbiome communities. BMC Genomics 2014;15:257.
22. Nazli A, Yang P-C, Jury J, et al. Epithelia under metabolic stress perceive commensal bacteria as a threat. Am J Pathol 2004;164:947–57.
23. Neish AS. Redox signaling mediated by the gut microbiota. Free Radic Res 2013;47:950–7.
24. Neish AS, Jones RM. Redox signaling mediates symbiosis between the gut microbiota and the intestine. Gut Microbes 2014;5:250–3.
25. Prakash S, Rodes L, Coussa-Charley M, et al. Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biologics 2011;5:71–86.
26. Remely M, Aumueller E, Merold C, et al. Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity. Gene 2014;537: 85–92.
27. Ricchetti M, Tekaia F, Dujon B. Continued colonization of the human genome by mitochondrial DNA. PLoS Biol 2004;2:E273.
28. Riley DR, Sieber KB, Robinson KM, et al. Bacteria-human somatic cell lateral gene transfer is enriched in cancer samples. PLoS Comput Biol 2013;9:e1003107.
29. Sartor RB, Mazmanian SK. Intestinal microbes in inflammatory bowel diseases. Am J Gastroenterol Suppl 2012;1:15–21.
30. Schröder G, Schuelein R, Quebatte M, et al. Conjugative DNA transfer into human cells by the VirB/VirD4 type IV secretion system of the bacterial pathogen Bartonella henselae. Proc Natl Acad Sci U S A 2011;108:14643–8.
31. Trinchese G, Cavaliere G, Canani RB, et al. Human, donkey and cow milk differently affects energy efficiency and inflammatory state by modulating mitochondrial function and gut microbiota. J Nutr Biochem 2015, DOI:10.1016/j.jnutbio.2015.05.003.
32. Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027–31.
33. Vermeiren J, Van de Wiele T, Van Nieuwenhuyse G, et al. Sulfide- and nitrite-dependent nitric oxide production in the intestinal tract. Microb Biotechnol 2012;5:379–87.
34. Walker MA, Volpi S, Sims KB, et al. Powering the immune system: mitochondria in immune function and deficiency. J Immunol Res 2014;2014:164309.
35. Wang A, Keita ÅV, Phan V, et al. Targeting mitochondria-derived reactive oxygen species to reduce epithelial barrier dysfunction and colitis. Am J Pathol 2014;184:2516–27.
36. Weissig V, Edeas M. Preface. In: Mitochondrial Medicine. Vol. II Manipulating Mitochondrial Function. Methods in Molecular Biology, New York, NY: Springer New York, 2015a;1265:v–xiv.
37. Weissig V, Edeas M. Preface. In: Mitochondrial Medicine. Vol. I Probing Mitochondrial Function. Methods in Molecular Biology, New York, NY: Springer New York, 2015b;1264:v–xiv.
38. Weissig V, Guzman-Villanueva D. Nanocarrier-based antioxidant therapy: promise or delusion? Expert Opin Drug Deliv 2015;12:1–8.
39. West AP, Brodsky IE, Rahner C, et al. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 2011;472:476–80.
40. Yadav H, Lee J-H, Lloyd J, et al. Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. J Biol Chem 2013;288:25088–97.
41. Zorov DB, Plotnikov EY, Silachev DN, et al. Microbiota and mito-biota. Putting an equal sign between mitochondria and bacteria. Biochemistry (Moscow) 2014;79:1017–31.